These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
253 related articles for article (PubMed ID: 34612554)
1. Serum exosomal long noncoding RNA CRNDE as a prognostic biomarker for hepatocellular carcinoma. Wang T; Zhu H; Xiao M; Zhou S J Clin Lab Anal; 2021 Nov; 35(11):e23959. PubMed ID: 34612554 [TBL] [Abstract][Full Text] [Related]
2. Exosomal long noncoding RNA CRNDE-h as a novel serum-based biomarker for diagnosis and prognosis of colorectal cancer. Liu T; Zhang X; Gao S; Jing F; Yang Y; Du L; Zheng G; Li P; Li C; Wang C Oncotarget; 2016 Dec; 7(51):85551-85563. PubMed ID: 27888803 [TBL] [Abstract][Full Text] [Related]
3. Increased serum exosomal long non-coding RNA SNHG15 expression predicts poor prognosis in non-small cell lung cancer. Han P; Zhao J; Gao L J Clin Lab Anal; 2021 Nov; 35(11):e23979. PubMed ID: 34551140 [TBL] [Abstract][Full Text] [Related]
4. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma. Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic and prognostic value of lncRNA cancer susceptibility candidate 9 in hepatocellular carcinoma. Zeng YL; Guo ZY; Su HZ; Zhong FD; Jiang KQ; Yuan GD World J Gastroenterol; 2019 Dec; 25(48):6902-6915. PubMed ID: 31908394 [TBL] [Abstract][Full Text] [Related]
6. Low expression of long noncoding RNA CTC-297N7.9 predicts poor prognosis in patients with hepatocellular carcinoma. Zhu S; Huang X; Zhang K; Tan W; Lin Z; He Q; Chen Y; Shang C Cancer Med; 2019 Dec; 8(18):7679-7692. PubMed ID: 31674731 [TBL] [Abstract][Full Text] [Related]
7. RNA sequencing of plasma exosomes revealed novel functional long noncoding RNAs in hepatocellular carcinoma. Huang X; Sun L; Wen S; Deng D; Wan F; He X; Tian L; Liang L; Wei C; Gao K; Fu Q; Li Y; Jiang J; Zhai R; He M Cancer Sci; 2020 Sep; 111(9):3338-3349. PubMed ID: 32506598 [TBL] [Abstract][Full Text] [Related]
8. lncRNA-D16366 Is a Potential Biomarker for Diagnosis and Prognosis of Hepatocellular Carcinoma. Chao Y; Zhou D Med Sci Monit; 2019 Sep; 25():6581-6586. PubMed ID: 31475695 [TBL] [Abstract][Full Text] [Related]
9. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma. Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933 [TBL] [Abstract][Full Text] [Related]
10. Serum small extracellular vesicle-derived LINC00853 as a novel diagnostic marker for early hepatocellular carcinoma. Kim SS; Baek GO; Ahn HR; Sung S; Seo CW; Cho HJ; Nam SW; Cheong JY; Eun JW Mol Oncol; 2020 Oct; 14(10):2646-2659. PubMed ID: 32525601 [TBL] [Abstract][Full Text] [Related]
11. Serum exosomal long noncoding RNAs lnc-FAM72D-3 and lnc-EPC1-4 as diagnostic biomarkers for hepatocellular carcinoma. Yao Z; Jia C; Tai Y; Liang H; Zhong Z; Xiong Z; Deng M; Zhang Q Aging (Albany NY); 2020 Jun; 12(12):11843-11863. PubMed ID: 32554864 [TBL] [Abstract][Full Text] [Related]
12. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value. Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302 [TBL] [Abstract][Full Text] [Related]
13. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma. Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618 [TBL] [Abstract][Full Text] [Related]
14. Downregulation of serum exosomal miR-320d predicts poor prognosis in hepatocellular carcinoma. Li W; Ding X; Wang S; Xu L; Yin T; Han S; Geng J; Sun W J Clin Lab Anal; 2020 Jun; 34(6):e23239. PubMed ID: 32125733 [TBL] [Abstract][Full Text] [Related]
15. Serum exosomal hnRNPH1 mRNA as a novel marker for hepatocellular carcinoma. Xu H; Dong X; Chen Y; Wang X Clin Chem Lab Med; 2018 Feb; 56(3):479-484. PubMed ID: 29252188 [TBL] [Abstract][Full Text] [Related]
16. lncRNA CRNDE promotes the proliferation and metastasis by acting as sponge miR-539-5p to regulate POU2F1 expression in HCC. Li Z; Wu G; Li J; Wang Y; Ju X; Jiang W BMC Cancer; 2020 Apr; 20(1):282. PubMed ID: 32252678 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic Potential of the Serum lncRNAs HOTAIR, BRM and ICR for Hepatocellular Carcinoma. Lou ZH; Xu KY; Qiao L; Su XQ; Ou-Yang Y; Miao LB; Liu F; Wang Y; Fu A; Ren XH; Huang JS; Li ZY; Bao JF Front Biosci (Landmark Ed); 2022 Sep; 27(9):264. PubMed ID: 36224021 [TBL] [Abstract][Full Text] [Related]
18. Circulating exosome-derived bona fide long non-coding RNAs predicting the occurrence and metastasis of hepatocellular carcinoma. Lu Y; Duan Y; Xu Q; Zhang L; Chen W; Qu Z; Wu B; Liu W; Shi L; Wu D; Yang Y; Sun D; Chen X J Cell Mol Med; 2020 Jan; 24(2):1311-1318. PubMed ID: 31811749 [TBL] [Abstract][Full Text] [Related]
19. Investigation of serum lncRNA-uc003wbd and lncRNA-AF085935 expression profile in patients with hepatocellular carcinoma and HBV. Lu J; Xie F; Geng L; Shen W; Sui C; Yang J Tumour Biol; 2015 May; 36(5):3231-6. PubMed ID: 25501706 [TBL] [Abstract][Full Text] [Related]
20. Serum Exosomal Long Noncoding RNAs Xu H; Chen Y; Dong X; Wang X Cancer Epidemiol Biomarkers Prev; 2018 Jun; 27(6):710-716. PubMed ID: 29650788 [No Abstract] [Full Text] [Related] [Next] [New Search]